← Leaderboards
Brigitte Widemann
Children'S Tumor Foundation
$723,242
Attributed
$1,426,483
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $578.9K · FY2012–19$1M$750K$500K$250K$0
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$1,426,483 · 2
By mechanism
U01$1,406,483 · 1
U13$20,000 · 1
Top collaborators
- Karen M Cichowski4 shared
Most similar at Children'S Tumor Foundation
Same institution · by research overlap
- Scott R Plotkin$5,244,687
- Jaishri O. Blakeley$10,000
- Michael Fisher$20,000
Others in their field
Top investigators on “Syndrome”
- David Heimbrook · Leidos Biomedical Research, Inc.$365,165,418
- George R Seage · Abt Associates, Inc.$241,364,559
- Barbara Driver · Westat, Inc.$177,853,041
- Michael David Hughes · Harvard University D/B/A Harvard School Of Public Health$174,377,607
- Michelle Vargas · Ppd Development Lp$163,846,102
- Judith S. Currier · University Of California Los Angeles$149,333,820
Research focus
SyndromeResearch PersonnelMalignant NeoplasmsSignal TransductionTumor GrowthCellsGeneticGenomicsPathway InteractionsScientistTranslational ResearchTumorCollaborationsUnited States National Institutes Of HealthAffectFoundationsClinicChildBench To BedsideClinical TrialsPre-ClinicalBackBiopsyBiology
Grant awards (5)
Developing a translational pipeline for NF1-mutant malignancies$212,444
U01 · FY2019 · CA
Developing a translational pipeline for NF1-mutant malignancies$235,046
U01 · FY2018 · CA
Developing a translational pipeline for NF1-mutant malignancies$380,076
U01 · FY2017 · CA
Developing a translational pipeline for NF1-mutant malignancies$578,917
U01 · FY2016 · CA
2012 Neurofibromatosis (NF) Conference$20,000
U13 · FY2012 · NS · contact PI